Polygiene Group AB
Polygiene Group AB is a specialty chemicals company that develops and markets odor control solutions for textiles, primarily through its silver-based antimicrobial technology.
Business. Polygiene Group AB (POLYG.ST) is a specialty chemicals company headquartered in Sweden and listed on the Nasdaq Stockholm exchange. The firm operates within the Basic Materials sector, specifically focusing on the development and production of specialty chemical formulations. As detailed segment and geographic breakdowns are not provided, the company is described at the industry level as a participant in the specialty chemicals market.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Polygiene Group AB (POLYG.ST) is a specialty chemicals company headquartered in Sweden and listed on the Nasdaq Stockholm exchange. The firm operates within the Basic Materials sector, specifically focusing on the development and production of specialty chemical formulations. As detailed segment and geographic breakdowns are not provided, the company is described at the industry level as a participant in the specialty chemicals market.
Polygiene maintains a strong liquidity position with a current ratio of 5.08 and cash and equivalents of 54.28 million SEK, representing 16.4% of total assets. The company's price-to-book ratio of 0.7 and price-to-tangible-book ratio of 0.7 indicate a significant discount to net asset value, while the debt-to-equity ratio of 0.01 shows minimal leverage.
The company reported a net loss of 745,000 SEK for the period, with a negative return on equity of -0.24% and return on assets of -0.23%. These metrics fall below the typical performance benchmarks for specialty chemicals firms, which usually maintain positive ROE above 10% and ROA above 5%.
Polygiene operates as a single-segment business with 100% revenue concentration in its core antimicrobial solutions. The company's geographic exposure is not disclosed in the available data, but its market capitalization of 215.5 million SEK suggests limited international scale compared to global specialty chemicals peers.
Analysts project a significant revenue increase to 175 million SEK for the current fiscal year, representing a 16.4% year-over-year growth from the 150.35 million SEK reported in the latest period. However, the company's negative net income of -0.15 SEK per share contrasts sharply with the 0.71 SEK mean EPS estimate.
The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's free cash flow of 321,000 SEK and capital expenditures of -802,000 SEK suggest modest reinvestment activity.
Recent analyst estimates show consensus price targets of 22.00 SEK, implying a 272% upside from the current market price of 5.9 SEK. This wide valuation gap reflects either significant growth expectations or potential mispricing in the current market.
- Polygiene trades at a significant discount to book value with a price-to-book ratio of 0.7
- The company has strong liquidity with 54.28 million SEK in cash and equivalents
- Analysts project a 16.4% revenue increase to 175 million SEK for the current fiscal year
- The current market price of 5.9 SEK is well below the 22.00 SEK analyst price target consensus
- Polygiene's negative ROE of -0.24% indicates poor capital efficiency compared to industry benchmarks
Bull / Bear case
Generated · model-assistedAnalysts project 350.8% upside to a consensus price target of 22.0 SEK, significantly above the current market price of 4.88 SEK.
The company maintains a very low debt-to-equity ratio of 0.01, ranking in the top quartile compared to the 0.23 cohort median.
Revenue stabilized at 156.9 million SEK in FY2025, marking a recovery from the 113.5 million SEK low recorded in FY2024.
Gross profit remained robust at 103.8 million SEK in FY2025, indicating strong underlying product margins despite operating losses.
Free cash flow turned positive to 9.1 million SEK in FY2025, reversing the severe negative cash flow seen in FY2024.
Return on equity of -0.24% places the company in the bottom quartile of its 244-company peer group.
In focus — financials by report
Revenue kr 36.8M, −17,6% YoY; Operating income −158,7% YoY.
- ▍Revenue kr 36.8M, −17,6% YoY
- ▍Operating income −158,7% YoY
- ▍Net income −193,0% YoY
- ▍Free cash flow −261,5% YoY
- ▍Net margin -9.6%
Revenue kr 36.4M, −10,9% YoY; Operating income −65,4% YoY.
- ▍Revenue kr 36.4M, −10,9% YoY
- ▍Operating income −65,4% YoY
- ▍Net income +168,8% YoY
- ▍Free cash flow −36,4% YoY
- ▍Net margin 5.0%
Revenue kr 31.9M, −12,2% YoY; Operating income −316,8% YoY.
- ▍Revenue kr 31.9M, −12,2% YoY
- ▍Operating income −316,8% YoY
- ▍Net income −418,5% YoY
- ▍Free cash flow −1 137,4% YoY
- ▍Net margin -12.1%
Revenue kr 41.5M; Operating income kr 1.6M.
- ▍Revenue kr 41.5M
- ▍Operating income kr 1.6M
- ▍Net margin 0.1%
Revenue kr 44.7M; Operating income kr 4.4M.
- ▍Revenue kr 44.7M
- ▍Operating income kr 4.4M
- ▍Net margin 8.5%
Revenue kr 40.8M; Operating income kr 4.2M.
- ▍Revenue kr 40.8M
- ▍Operating income kr 4.2M
- ▍Net margin 1.7%
Revenue kr 36.4M; Operating income kr 1.2M.
- ▍Revenue kr 36.4M
- ▍Operating income kr 1.2M
- ▍Net margin -2.0%
Revenue kr 146.6M, −6,6% YoY; Operating income −115,9% YoY.
- ▍Revenue kr 146.6M, −6,6% YoY
- ▍Operating income −115,9% YoY
- ▍Net income −215,2% YoY
- ▍Free cash flow −254,0% YoY
- ▍Net margin -3.8%
Revenue kr 156.9M, +38,2% YoY; Operating income +104,2% YoY.
- ▍Revenue kr 156.9M, +38,2% YoY
- ▍Operating income +104,2% YoY
- ▍Net income +101,5% YoY
- ▍Free cash flow +102,8% YoY
- ▍Net margin 3.1%
Revenue kr 113.5M, −34,6% YoY; Operating income −2 054,7% YoY.
- ▍Revenue kr 113.5M, −34,6% YoY
- ▍Operating income −2 054,7% YoY
- ▍Net income −3 952,0% YoY
- ▍Free cash flow −792,2% YoY
- ▍Net margin -283.5%
Revenue kr 173.6M, −4,4% YoY; Operating income −60,9% YoY.
- ▍Revenue kr 173.6M, −4,4% YoY
- ▍Operating income −60,9% YoY
- ▍Net income −74,5% YoY
- ▍Free cash flow −213,8% YoY
- ▍Net margin 4.8%
Revenue kr 181.6M; Operating income kr 40.9M.
- ▍Revenue kr 181.6M
- ▍Operating income kr 40.9M
- ▍Net margin 18.1%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,71 |
| Revenue | —no estimate | —no estimate | 175,0M SEK |
| Operating income | —no estimate | —no estimate | 30,0M SEK |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Polygiene Group AB Market data — financials · 2026-05-29
- Polygiene Group AB Market data — analyst estimates · 2026-05-29
- Polygiene Group AB Market data — ESG · 2026-05-29